SEC Filings TLDR

Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC, and Kenneth Griffin have jointly filed a Schedule 13G with the SEC regarding their ownership in Safe Pro Group Inc. The filing indicates that Citadel Advisors LLC, Citadel ...

HONGKONG BOYATONG SUPPLY CHAIN MANAGEMENT CORPORATION LIMITED has filed a Schedule 13G indicating ownership of 11,947,899 Class A Ordinary Shares of Jayud Global Logistics Ltd, representing 9.10% of the total issued and outstanding shares. The filing, made under Rule 13d-1(c), certifies that the shares were not acquire...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing a 5.2% ownership stake in Design Therapeutics, Inc. The filing indicates that Point72 Asset Management holds investment and voting power over the shares through Point72 Associat...

Maple Rock Capital Partners Inc. and Xavier Majic have filed a Schedule 13G with the SEC, indicating that they no longer hold common shares of Algoma Steel Group Inc. for the purpose of influencing control of the issuer. The filing, dated August 28, 2025, amends a previous Schedule 13D filed on October 25, 2024. The Re...

A Schedule 13G filing was submitted by Paradigm BioCapital Advisors LP, Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd. regarding their beneficial ownership of common stock in Agios Pharmaceuticals, Inc. The filing indicates that these entities collectively own 5...

Durable Capital Partners LP, a limited partnership organized under the laws of the State of Delaware, has reported a 5.5% ownership stake in CBIZ, Inc. The filing, submitted under Rule 13d-1(b), indicates that Durable Capital Partners LP holds 2,939,563 shares of CBIZ's Common Stock, $0.01 par value. The shares are dir...

Leon G. Cooperman, through Omega Capital Partners, L.P., has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 6,647,109 common shares of SunOpta Inc., representing approximately 5.6% of the total outstanding shares. The filing, made under Rule 13d-1(c), indicates that the shares were not acquired f...

Alumni Capital LP, along with its general partner Alumni Capital GP LLC and controlling person Ashkan Mapar, filed a Schedule 13G with the SEC on August 27, 2025, reporting beneficial ownership of 9.99% of the common stock of Treasure Global Inc. The filing indicates that Alumni Capital LP currently owns 310,000 shares...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 730,000 shares of Calidi Biotherapeutics, Inc.'s common stock, representing 14.46% of the total outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositiv...

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G with the SEC, disclosing an 8% beneficial ownership in Invivyd, Inc. The filing, dated August 26, 2025, indicates that Point72 Asset Management holds 16,730,467 shares of common stock through Point72 Asso...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 750,000 shares of common stock in Vision Marine Technologies Inc., representing 16.10% of the outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over ...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 1,230,769 shares of Class A Common Stock in Celularity Inc, representing 5.14% of the total outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over th...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 1,176,470 shares of Class A Common Stock in Longeveron Inc., representing 6.09% of the total shares outstanding. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over t...

Leon G. Cooperman has filed a Schedule 13G with the SEC, disclosing his beneficial ownership of 6,530,945 common shares of Fidelis Insurance Holdings Ltd, representing approximately 6.2% of the total outstanding shares. The shares are held through various entities, including Omega Capital Partners, L.P., a UTMA account...

Leon G. Cooperman has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 3,110,220 common shares of DiaMedica Therapeutics Inc., representing approximately 6.0% of the total outstanding shares. The shares are held directly by Mr. Cooperman and The Leon and Toby Cooperman Foundation. The filing indica...

Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC have filed a Schedule 13G indicating their ownership of 9.99% of iBio, Inc.'s common stock. The filing, dated August 26, 2025, reveals that the Fund beneficially owns 4,280,000 shares of Common Stock, issuable upon exercise of warrants, subject to a benefici...

True Thrive Limited, 360 Technology Group Co., Ltd., and Hongyi Zhou have filed a Schedule 13G indicating their beneficial ownership of Class A Ordinary Shares in Gamehaus Holdings Inc. True Thrive Limited directly holds 5,647,138 shares, representing 14.87% of the class. These shares are 100% owned by 360 Technology G...

Soul Ventures Holdings Ltd, a British Virgin Islands entity, has filed a Schedule 13G indicating its ownership of 11,333,200 shares of Common Stock in ALT5 Sigma Corp, representing 9.2% of the outstanding shares. The filing, made under Rule 13d-1(c), states that Soul Ventures Holdings Ltd has sole voting and dispositiv...

Mark Paley has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 10,555,000 common shares of RLJ Lodging Trust, representing 6.97% of the outstanding shares. The filing indicates that these shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(c) and includes...

Coastlands Capital LP, along with its affiliates Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry, have reported a 5.98% ownership in Whitehawk Therapeutics, Inc. The ownership is based on 2,819,215 shares of common stock, calculated from the 47,128,362 shares outs...

The SEC filing details the ownership of Class A ordinary shares in TIAN RUIXIANG Holdings Ltd by Eastern Bell International XXVII Limited and related entities, including Eastern Bell Capital Fund II, L.P., Eastern Bell Capital II Limited, Yan Capital Limited, and Li Yan. Eastern Bell International XXVII Limited directl...

This Schedule 13G filing, submitted on August 25, 2025, reports the beneficial ownership of common stock in LM Funding America, Inc. by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. The filing indicates that the Reporting Persons collectively own 405,440 shares, representing approximately 2.7% of th...

L1 Capital Global Opportunities Master Fund, Ltd. has reported a 9.28% ownership in LM Funding America, Inc. as of August 18, 2025. The fund holds 1,410,790 shares of common stock, with sole voting and dispositive power over these shares. The filing indicates that the shares were not acquired for the purpose of influen...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have filed a Schedule 13G indicating a 9.9% beneficial ownership in iBio, Inc. The ownership includes 14,280,000 shares of common stock issuable upon exercise of warrants, subject to a 9.99% blocker. The filing is made jointly under Rul...

This Schedule 13G filing reports the ownership of Class B Common Stock in Asset Entities Inc. by several Citadel entities and Kenneth Griffin. Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC each beneficially own 883,573 shares, representing 5.7% of the outstanding shares. Citadel Securities LLC,...